Literature DB >> 25809628

Therapeutic value of black seed oil in methotrexate hepatotoxicity in Egyptian children with acute lymphoblastic leukemia.

Adel A Hagag1, Ahmed M AbdElaal, Mohamed S Elfaragy, Samir M Hassan, Enas A Elzamarany.   

Abstract

BACKGROUND: 'Acute lymphoblastic leukemia is the most common childhood malignancy'. Adding methotrexate to treatment protocols increased survival rate in children with leukemia. Methotrexate efficacy is limited by its hepatotoxicity. AIM OF THE STUDY: To assess the therapeutic value of Black seed oil in 'methotrexate induced hepatotoxicity in Egyptian children with acute lymphoblastic leukemia'. SUBJECTS AND METHODS: This study was conducted on 40 children with acute lymphoblastic leukemia' including 20 patients under methotrexate therapy and Black seeds 80 mg/kg/day for one week after each methotrexate dose [Group II] and 20 patients under methotrexate therapy and placebo [Group III]. This study included also '20 healthy children of matched age and sex as a control group' [Group I]. All patients were subjected to complete blood picture, bone marrow aspiration and liver functions.
RESULTS: No significant differences in liver functions between group II and III before therapy were observed. There were nonsignificant increase in total, direct and indirect serum bilirubin, serum ALT, AST, and alkaline phosphatase levels and prothrombin time in group II after methotrexate and Black seed oil therapy but there was significant increase in group III after treatment with methotrexate and placebo with 'significant differences between group II and III ' after therapy. There were significant differences in prognosis regarding remission, relapse, death and 'disease free survival but no significant difference in overall survival between group II and III'.
CONCLUSION: Black cumin seeds decreased MTX hepatotoxicity and improved survival in children with ALL and can be recommended as adjuvant drug in patients with ALL under methotrexate therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25809628     DOI: 10.2174/1871526515666150320161440

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  7 in total

Review 1.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

2.  A systematic review of integrative clinical trials for supportive care in pediatric oncology: a report from the International Society of Pediatric Oncology, T&CM collaborative.

Authors:  Andrea L Radossi; Katherine Taromina; Stacey Marjerrison; Caroline J Diorio; Raquel Similio; Festus Njuguna; Glenn M Afungchwi; Elena J Ladas
Journal:  Support Care Cancer       Date:  2017-10-13       Impact factor: 3.603

3.  Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia.

Authors:  Adel A Hagag; Mohamed A Elgamsy; Hassan M El-Asy; Maaly M Mabrouk
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-09-01       Impact factor: 2.576

Review 4.  Protective Effects of Chrysin Against Drugs and Toxic Agents.

Authors:  Saeed Samarghandian; Tahereh Farkhondeh; Mohsen Azimi-Nezhad
Journal:  Dose Response       Date:  2017-06-23       Impact factor: 2.658

Review 5.  Black Seed (Nigella Sativa) and its Constituent Thymoquinone as an Antidote or a Protective Agent Against Natural or Chemical Toxicities.

Authors:  Alireza Tavakkoli; Ali Ahmadi; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 6.  Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone.

Authors:  Alireza Tavakkoli; Vahid Mahdian; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  J Pharmacopuncture       Date:  2017-09-30

7.  Local Usage of Nigella sativa Oil as an Innovative Method to Attenuate Primary Dysmenorrhea: A Randomized Double-blind Clinical Trial.

Authors:  Ezat Samadipour; Mohammad Hassan Rakhshani; Akram Kooshki; Bahareh Amin
Journal:  Oman Med J       Date:  2020-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.